Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Acute Intermittent Porphyria Revenue 1.4 Market Analysis by Type 1.4.1 Global Acute Intermittent Porphyria Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Gonadotropin-Releasing Hormone Analogues 1.4.3 Prophylactic Hematin Infusions 1.5 Market by Application 1.5.1 Global Acute Intermittent Porphyria Market Share by Application: 2020 VS 2026 1.5.2 Hospitals & Clinics 1.5.3 Research Centers 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Acute Intermittent Porphyria Market Perspective (2015-2026) 2.2 Acute Intermittent Porphyria Growth Trends by Regions 2.2.1 Acute Intermittent Porphyria Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Acute Intermittent Porphyria Historic Market Share by Regions (2015-2020) 2.2.3 Acute Intermittent Porphyria Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Acute Intermittent Porphyria Market Growth Strategy 2.3.6 Primary Interviews with Key Acute Intermittent Porphyria Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Acute Intermittent Porphyria Players by Market Size 3.1.1 Global Top Acute Intermittent Porphyria Players by Revenue (2015-2020) 3.1.2 Global Acute Intermittent Porphyria Revenue Market Share by Players (2015-2020) 3.1.3 Global Acute Intermittent Porphyria Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Acute Intermittent Porphyria Market Concentration Ratio 3.2.1 Global Acute Intermittent Porphyria Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Acute Intermittent Porphyria Revenue in 2019 3.3 Acute Intermittent Porphyria Key Players Head office and Area Served 3.4 Key Players Acute Intermittent Porphyria Product Solution and Service 3.5 Date of Enter into Acute Intermittent Porphyria Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Acute Intermittent Porphyria Historic Market Size by Type (2015-2020) 4.2 Global Acute Intermittent Porphyria Forecasted Market Size by Type (2021-2026) 5 Acute Intermittent Porphyria Breakdown Data by Application (2015-2026) 5.1 Global Acute Intermittent Porphyria Market Size by Application (2015-2020) 5.2 Global Acute Intermittent Porphyria Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Acute Intermittent Porphyria Market Size (2015-2020) 6.2 Acute Intermittent Porphyria Key Players in North America (2019-2020) 6.3 North America Acute Intermittent Porphyria Market Size by Type (2015-2020) 6.4 North America Acute Intermittent Porphyria Market Size by Application (2015-2020) 7 Europe 7.1 Europe Acute Intermittent Porphyria Market Size (2015-2020) 7.2 Acute Intermittent Porphyria Key Players in Europe (2019-2020) 7.3 Europe Acute Intermittent Porphyria Market Size by Type (2015-2020) 7.4 Europe Acute Intermittent Porphyria Market Size by Application (2015-2020) 8 China 8.1 China Acute Intermittent Porphyria Market Size (2015-2020) 8.2 Acute Intermittent Porphyria Key Players in China (2019-2020) 8.3 China Acute Intermittent Porphyria Market Size by Type (2015-2020) 8.4 China Acute Intermittent Porphyria Market Size by Application (2015-2020) 9 Japan 9.1 Japan Acute Intermittent Porphyria Market Size (2015-2020) 9.2 Acute Intermittent Porphyria Key Players in Japan (2019-2020) 9.3 Japan Acute Intermittent Porphyria Market Size by Type (2015-2020) 9.4 Japan Acute Intermittent Porphyria Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Acute Intermittent Porphyria Market Size (2015-2020) 10.2 Acute Intermittent Porphyria Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Acute Intermittent Porphyria Market Size by Type (2015-2020) 10.4 Southeast Asia Acute Intermittent Porphyria Market Size by Application (2015-2020) 11 India 11.1 India Acute Intermittent Porphyria Market Size (2015-2020) 11.2 Acute Intermittent Porphyria Key Players in India (2019-2020) 11.3 India Acute Intermittent Porphyria Market Size by Type (2015-2020) 11.4 India Acute Intermittent Porphyria Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Acute Intermittent Porphyria Market Size (2015-2020) 12.2 Acute Intermittent Porphyria Key Players in Central & South America (2019-2020) 12.3 Central & South America Acute Intermittent Porphyria Market Size by Type (2015-2020) 12.4 Central & South America Acute Intermittent Porphyria Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Dahaner 13.1.1 Dahaner Company Details 13.1.2 Dahaner Business Overview and Its Total Revenue 13.1.3 Dahaner Acute Intermittent Porphyria Introduction 13.1.4 Dahaner Revenue in Acute Intermittent Porphyria Business (2015-2020)) 13.1.5 Dahaner Recent Development 13.2 Roche 13.2.1 Roche Company Details 13.2.2 Roche Business Overview and Its Total Revenue 13.2.3 Roche Acute Intermittent Porphyria Introduction 13.2.4 Roche Revenue in Acute Intermittent Porphyria Business (2015-2020) 13.2.5 Roche Recent Development 13.3 Bio-Rad Laboratories 13.3.1 Bio-Rad Laboratories Company Details 13.3.2 Bio-Rad Laboratories Business Overview and Its Total Revenue 13.3.3 Bio-Rad Laboratories Acute Intermittent Porphyria Introduction 13.3.4 Bio-Rad Laboratories Revenue in Acute Intermittent Porphyria Business (2015-2020) 13.3.5 Bio-Rad Laboratories Recent Development 13.4 Siemens 13.4.1 Siemens Company Details 13.4.2 Siemens Business Overview and Its Total Revenue 13.4.3 Siemens Acute Intermittent Porphyria Introduction 13.4.4 Siemens Revenue in Acute Intermittent Porphyria Business (2015-2020) 13.4.5 Siemens Recent Development 13.5 ARKRAY 13.5.1 ARKRAY Company Details 13.5.2 ARKRAY Business Overview and Its Total Revenue 13.5.3 ARKRAY Acute Intermittent Porphyria Introduction 13.5.4 ARKRAY Revenue in Acute Intermittent Porphyria Business (2015-2020) 13.5.5 ARKRAY Recent Development 13.6 Sysmex Corporation 13.6.1 Sysmex Corporation Company Details 13.6.2 Sysmex Corporation Business Overview and Its Total Revenue 13.6.3 Sysmex Corporation Acute Intermittent Porphyria Introduction 13.6.4 Sysmex Corporation Revenue in Acute Intermittent Porphyria Business (2015-2020) 13.6.5 Sysmex Corporation Recent Development 13.7 ACON Laboratories 13.7.1 ACON Laboratories Company Details 13.7.2 ACON Laboratories Business Overview and Its Total Revenue 13.7.3 ACON Laboratories Acute Intermittent Porphyria Introduction 13.7.4 ACON Laboratories Revenue in Acute Intermittent Porphyria Business (2015-2020) 13.7.5 ACON Laboratories Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Acute Intermittent Porphyria Key Market Segments Table 2. Key Players Covered: Ranking by Acute Intermittent Porphyria Revenue Table 3. Ranking of Global Top Acute Intermittent Porphyria Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Acute Intermittent Porphyria Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Gonadotropin-Releasing Hormone Analogues Table 6. Key Players of Prophylactic Hematin Infusions Table 7. Global Acute Intermittent Porphyria Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Acute Intermittent Porphyria Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Acute Intermittent Porphyria Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Acute Intermittent Porphyria Market Share by Regions (2015-2020) Table 11. Global Acute Intermittent Porphyria Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Acute Intermittent Porphyria Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Acute Intermittent Porphyria Market Growth Strategy Table 17. Main Points Interviewed from Key Acute Intermittent Porphyria Players Table 18. Global Acute Intermittent Porphyria Revenue by Players (2015-2020) (Million US$) Table 19. Global Acute Intermittent Porphyria Market Share by Players (2015-2020) Table 20. Global Top Acute Intermittent Porphyria Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Intermittent Porphyria as of 2019) Table 21. Global Acute Intermittent Porphyria by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Acute Intermittent Porphyria Product Solution and Service Table 24. Date of Enter into Acute Intermittent Porphyria Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$) Table 27. Global Acute Intermittent Porphyria Market Size Share by Type (2015-2020) Table 28. Global Acute Intermittent Porphyria Revenue Market Share by Type (2021-2026) Table 29. Global Acute Intermittent Porphyria Market Size Share by Application (2015-2020) Table 30. Global Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$) Table 31. Global Acute Intermittent Porphyria Market Size Share by Application (2021-2026) Table 32. North America Key Players Acute Intermittent Porphyria Revenue (2019-2020) (Million US$) Table 33. North America Key Players Acute Intermittent Porphyria Market Share (2019-2020) Table 34. North America Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$) Table 35. North America Acute Intermittent Porphyria Market Share by Type (2015-2020) Table 36. North America Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$) Table 37. North America Acute Intermittent Porphyria Market Share by Application (2015-2020) Table 38. Europe Key Players Acute Intermittent Porphyria Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Acute Intermittent Porphyria Market Share (2019-2020) Table 40. Europe Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$) Table 41. Europe Acute Intermittent Porphyria Market Share by Type (2015-2020) Table 42. Europe Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$) Table 43. Europe Acute Intermittent Porphyria Market Share by Application (2015-2020) Table 44. China Key Players Acute Intermittent Porphyria Revenue (2019-2020) (Million US$) Table 45. China Key Players Acute Intermittent Porphyria Market Share (2019-2020) Table 46. China Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$) Table 47. China Acute Intermittent Porphyria Market Share by Type (2015-2020) Table 48. China Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$) Table 49. China Acute Intermittent Porphyria Market Share by Application (2015-2020) Table 50. Japan Key Players Acute Intermittent Porphyria Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Acute Intermittent Porphyria Market Share (2019-2020) Table 52. Japan Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$) Table 53. Japan Acute Intermittent Porphyria Market Share by Type (2015-2020) Table 54. Japan Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$) Table 55. Japan Acute Intermittent Porphyria Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Acute Intermittent Porphyria Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Acute Intermittent Porphyria Market Share (2019-2020) Table 58. Southeast Asia Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Acute Intermittent Porphyria Market Share by Type (2015-2020) Table 60. Southeast Asia Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Acute Intermittent Porphyria Market Share by Application (2015-2020) Table 62. India Key Players Acute Intermittent Porphyria Revenue (2019-2020) (Million US$) Table 63. India Key Players Acute Intermittent Porphyria Market Share (2019-2020) Table 64. India Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$) Table 65. India Acute Intermittent Porphyria Market Share by Type (2015-2020) Table 66. India Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$) Table 67. India Acute Intermittent Porphyria Market Share by Application (2015-2020) Table 68. Central & South America Key Players Acute Intermittent Porphyria Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Acute Intermittent Porphyria Market Share (2019-2020) Table 70. Central & South America Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Acute Intermittent Porphyria Market Share by Type (2015-2020) Table 72. Central & South America Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Acute Intermittent Porphyria Market Share by Application (2015-2020) Table 74. Dahaner Company Details Table 75. Dahaner Business Overview Table 76. Dahaner Product Table 77. Dahaner Revenue in Acute Intermittent Porphyria Business (2015-2020) (Million US$) Table 78. Dahaner Recent Development Table 79. Roche Company Details Table 80. Roche Business Overview Table 81. Roche Product Table 82. Roche Revenue in Acute Intermittent Porphyria Business (2015-2020) (Million US$) Table 83. Roche Recent Development Table 84. Bio-Rad Laboratories Company Details Table 85. Bio-Rad Laboratories Business Overview Table 86. Bio-Rad Laboratories Product Table 87. Bio-Rad Laboratories Revenue in Acute Intermittent Porphyria Business (2015-2020) (Million US$) Table 88. Bio-Rad Laboratories Recent Development Table 89. Siemens Company Details Table 90. Siemens Business Overview Table 91. Siemens Product Table 92. Siemens Revenue in Acute Intermittent Porphyria Business (2015-2020) (Million US$) Table 93. Siemens Recent Development Table 94. ARKRAY Company Details Table 95. ARKRAY Business Overview Table 96. ARKRAY Product Table 97. ARKRAY Revenue in Acute Intermittent Porphyria Business (2015-2020) (Million US$) Table 98. ARKRAY Recent Development Table 99. Sysmex Corporation Company Details Table 100. Sysmex Corporation Business Overview Table 101. Sysmex Corporation Product Table 102. Sysmex Corporation Revenue in Acute Intermittent Porphyria Business (2015-2020) (Million US$) Table 103. Sysmex Corporation Recent Development Table 104. ACON Laboratories Company Details Table 105. ACON Laboratories Business Overview Table 106. ACON Laboratories Product Table 107. ACON Laboratories Revenue in Acute Intermittent Porphyria Business (2015-2020) (Million US$) Table 108. ACON Laboratories Recent Development Table 109. Research Programs/Design for This Report Table 110. Key Data Information from Secondary Sources Table 111. Key Data Information from Primary Sources List of Figures Figure 1. Global Acute Intermittent Porphyria Market Share by Type: 2020 VS 2026 Figure 2. Gonadotropin-Releasing Hormone Analogues Features Figure 3. Prophylactic Hematin Infusions Features Figure 4. Global Acute Intermittent Porphyria Market Share by Application: 2020 VS 2026 Figure 5. Hospitals & Clinics Case Studies Figure 6. Research Centers Case Studies Figure 7. Acute Intermittent Porphyria Report Years Considered Figure 8. Global Acute Intermittent Porphyria Market Size YoY Growth 2015-2026 (US$ Million) Figure 9. Global Acute Intermittent Porphyria Market Share by Regions: 2020 VS 2026 Figure 10. Global Acute Intermittent Porphyria Market Share by Regions (2021-2026) Figure 11. Porter's Five Forces Analysis Figure 12. Global Acute Intermittent Porphyria Market Share by Players in 2019 Figure 13. Global Top Acute Intermittent Porphyria Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Intermittent Porphyria as of 2019 Figure 14. The Top 10 and 5 Players Market Share by Acute Intermittent Porphyria Revenue in 2019 Figure 15. North America Acute Intermittent Porphyria Market Size YoY Growth (2015-2020) (Million US$) Figure 16. Europe Acute Intermittent Porphyria Market Size YoY Growth (2015-2020) (Million US$) Figure 17. China Acute Intermittent Porphyria Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Japan Acute Intermittent Porphyria Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Southeast Asia Acute Intermittent Porphyria Market Size YoY Growth (2015-2020) (Million US$) Figure 20. India Acute Intermittent Porphyria Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Central & South America Acute Intermittent Porphyria Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Dahaner Total Revenue (US$ Million): 2019 Compared with 2018 Figure 23. Dahaner Revenue Growth Rate in Acute Intermittent Porphyria Business (2015-2020) Figure 24. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Roche Revenue Growth Rate in Acute Intermittent Porphyria Business (2015-2020) Figure 26. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Bio-Rad Laboratories Revenue Growth Rate in Acute Intermittent Porphyria Business (2015-2020) Figure 28. Siemens Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Siemens Revenue Growth Rate in Acute Intermittent Porphyria Business (2015-2020) Figure 30. ARKRAY Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. ARKRAY Revenue Growth Rate in Acute Intermittent Porphyria Business (2015-2020) Figure 32. Sysmex Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Sysmex Corporation Revenue Growth Rate in Acute Intermittent Porphyria Business (2015-2020) Figure 34. ACON Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. ACON Laboratories Revenue Growth Rate in Acute Intermittent Porphyria Business (2015-2020) Figure 36. Bottom-up and Top-down Approaches for This Report Figure 37. Data Triangulation Figure 38. Key Executives Interviewed

Dahaner Roche Bio-Rad Laboratories Siemens ARKRAY Sysmex Corporation ACON Laboratories